Angiogenesis and its role in colorectal tumor and metastasis formation

Seminars in Oncology

Volumn 31, Issue SUPPL. 17, 2004, Pages 3-9

  Ellis, Lee M ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANGIOGENIC FACTOR; ANGIOGENIN; ANGIOPOIETIN; ANGIOPOIETIN RECEPTOR; ANTINEOPLASTIC AGENT; BEVACIZUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR; INTEGRIN; MONOCLONAL ANTIBODY; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THROMBOSPONDIN; THROMBOSPONDIN 1; THROMBOSPONDIN 2; THYMIDINE PHOSPHORYLASE; TRANSFORMING GROWTH FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN ANTIBODY; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CLINICAL TRIAL; COLORECTAL CANCER; COLORECTAL TUMOR; DRUG MECHANISM; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS; NONHUMAN; PRIORITY JOURNAL;

ANGIOGENESIS INDUCING AGENTS; ANGIOGENESIS INHIBITORS; ANGIOPOIETINS; ANIMALS; COLORECTAL NEOPLASMS; HUMANS; INTEGRINS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; PLATELET-DERIVED GROWTH FACTOR; RECEPTOR, TIE-2; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; RIBONUCLEASE, PANCREATIC; THROMBOSPONDINS; THYMIDINE PHOSPHORYLASE; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 13244291423     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2004.11.028     Document Type: Article

References (82)

1. R.A. Ezekowitz, J.B. Mulliken, J. Folkman Interferon alfa-2a therapy for life-threatening hemangiomas of infancy N Engl J Med 326 1992 1456 1463
2. N. Ferrara Vascular endothelial growth factor and the regulation of angiogenesis Recent Prog Horm Res 55 2000 15 35 discussion 35-36
3. D. Hanahan, G. Christofori, P. Naik Transgenic mouse models of tumour angiogenesis The angiogenic switch, its molecular controls, and prospects for preclinical therapeutic models Eur J Cancer 32A 1996 2386 2393
4. D. Fukumura, R. Xavier, T. Sugiura Tumor induction of VEGF promoter activity in stromal cells Cell 94 1998 715 725
5. I. Fidler, R. Kerbel, L. Ellis Biology of cancer Angiogenesis V.T. DeVita S. Hellman S.A. Rosenberg Cancer Principles and Practice of Oncology 2001 Lippincott Williams & Wilkins Philadelphia, PA 137 147
6. I.J. Fidler, L.M. Ellis The implications of angiogenesis for the biology and therapy of cancer metastasis Cell 79 1994 185 188
7. I.J. Fidler, R. Kumar, D.R. Bielenberg Molecular determinants of angiogenesis in cancer metastasis Cancer J Sci Am 4 suppl 1 1998 S58 S66
8. L.M. Ellis, I.J. Fidler Angiogenesis and metastasis Eur J Cancer 32A 1996 2451 2460
9. L.M. Ellis, Y. Takahashi, C.J. Fenoglio Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma Eur J Cancer 34 1998 337 340
10. J. Folkman What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82 1990 4 6
11. C.J. Bruns, M.T. Harbison, D.W. Davis Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms Clin Cancer Res 6 2000 1936 1948
12. Y. Takahashi, Y. Kitadai, C.D. Bucana Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer Cancer Res 55 1995 3964 3968
13. Y. Takahashi, S.L. Tucker, Y. Kitadai Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer Arch Surg 132 1997 541 546
14. Y. Takebayashi, S. Aklyama, K. Yamada Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma Cancer 78 1996 226 231
15. P.B. Vermeulen, G.G. Van den Eynden, P. Huget Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer Br J Cancer 79 1999 316 322
16. C.J. Bruns, W. Liu, D.W. Davis Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases Cancer 89 2000 488 499
17. Y. Kondo, S. Arii, A. Mori Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line Clin Cancer Res 6 2000 622 630
18. T. Andre, L. Kotelevets, J.C. Vaillant Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa Int J Cancer 86 2000 174 181
19. R.M. Shaheen, D.W. Davis, W. Liu Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis Cancer Res 59 1999 5412 5416
20. R.M. Shaheen, W.W. Tseng, D.W. Davis Tyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanisms Cancer Res 61 2001 1464 1468
21. R.M. Shaheen, S.A. Ahmad, W. Liu Inhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptors Br J Cancer 85 2001 584 589
22. R.M. Shaheen, W.W. Tseng, R. Vellagas Effects of an antibody to vascular endothelial growth factor receptor-2 on survival, tumor vascularity, and apoptosis in a murine model of colon carcinomatosis Int J Oncol 18 2001 221 226
23. H.F. Dvorak, L.F. Brown, M. Detmar Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis Am J Pathol 146 1995 1029 1039
24. T. Matsumoto, L. Claesson-Welsh VEGF receptor signal transduction Sci STKE 2001 2001 RE21
25. M.L. Gagnon, D.R. Bielenberg, Z. Gechtman Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor In vivo expression and antitumor activity Proc Natl Acad Sci U S A 97 2000 2573 2578
26. O. Stoeltzing, W. Liu, N. Reinmuth Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis Ann Surg Oncol 10 2003 722 733
27. M. Stimpfl, D. Tong, B. Fasching Vascular endothelial growth factor splice variants and their prognostic value in breast and ovarian cancer Clin Cancer Res 8 2002 2253 2259
28. B.K. Zebrowski, S. Yano, W. Liu Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions Clin Cancer Res 5 1999 3364 3368
29. B.K. Zebrowski, W. Liu, K. Ramirez Markedly elevated levels of vascular endothelial growth factor in malignant ascites Ann Surg Oncol 6 1999 373 378
30. L.S. Rosen Clinical experience with angiogenesis signaling inhibitors Focus on vascular endothelial growth factor (VEGF) blockers Cancer Control 9 2002 36 44
31. A. Luttun, M. Tjwa, L. Moons Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 Nat Med 8 2002 831 840
32. Y. Wu, C. Costa, S. Dias Monoclonal antibody against VEGFR1 inhibits flt-1 positive breast tumor growth by a dual mechanism involving anti-endothelial and anti-tumor cell growth activities Proc Am Assoc Cancer Res 43 2002 527 (abstr 2613)
33. Y. He, K. Kozaki, T. Karpanen Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling J Natl Cancer Inst 94 2002 819 825
34. S. Soker, S. Takashima, H.Q. Miao Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor Cell 92 1998 735 745
35. A.A. Parikh, F. Fan, W.B. Liu Neuropilin-1 in human colon cancer Expression, regulation, and role in induction of angiogenesis Am J Pathol 164 2004 2139 2151
36. F. Ishikawa, K. Miyazono, U. Hellman Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor Nature 338 1989 557 562
37. Y. Kitadai, L.M. Ellis, S.L. Tucker Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma Am J Pathol 149 1996 1541 1551
38. H. Amaya, N. Tanigawa, C. Lu Association of vascular endothelial growth factor expression with tumor angiogenesis, survival and thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in human colorectal cancer Cancer Lett 119 1997 227 235
39. T. Saeki, M. Tanada, S. Takashima Correlation between expression of platelet-derived endothelial cell growth factor (thymidine phosphorylase) and microvessel density in early-stage human colon carcinomas Jpn J Clin Oncol 27 1997 227 230
40. C. Betsholtz, L. Karlsson, P. Lindahl Developmental roles of platelet-derived growth factors Bioessays 23 2001 494 507
41. M. Hellstrom, M. Kalen, P. Lindahl Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse Development 126 1999 3047 3055
42. S. Hsu, F. Huang, E. Friedman Platelet-derived growth factor-B increases colon cancer cell growth in vivo by a paracrine effect J Cell Physiol 165 1995 239 245
43. N. Reinmuth, W. Liu, Y.D. Jung Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival FASEB J 15 2001 1239 1241
44. M.E. Beckner Factors promoting tumor angiogenesis Cancer Invest 17 1999 594 623
45. S. Shimoyama, K. Yamasaki, M. Kawahara Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression Clin Cancer Res 5 1999 1125 1130
46. T. Etoh, K. Shibuta, G.F. Barnard Angiogenin expression in human colorectal cancer The role of focal macrophage infiltration Clin Cancer Res 6 2000 3545 3551
47. A. Papapetropoulos, G. Garcia-Cardena, T.J. Dengler Direct actions of angiopoietin-1 on human endothelium Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors Lab Invest 79 1999 213 223
48. J. Lauren, Y. Gunji, K. Alitalo Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am J Pathol 153 1998 1333 1339
49. S. Davis, G.D. Yancopoulos The angiopoietins Yin and Yang in angiogenesis Curr Top Microbiol Immunol 237 1999 173 185
50. G. Thurston Role of angiopoietins and Tie receptor tyrosine kinases in angiogenesis and lymphangiogenesis Cell Tissue Res 314 2003 61 68
51. S. Ahmad, W. Liu, Y. Jung Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma Possible mechanism for initiation of angiogenesis Cancer 92 2001 1138 1143
52. O. Stoeltzing, S.A. Ahmad, W. Liu Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors Cancer Res 63 2003 3370 3377
53. S.A. Ahmad, W. Liu, Y.D. Jung The effects of angiopoietin-1 and -2 on tumor growth and angiogenesis in human colon cancer Cancer Res 61 2001 1255 1259
54. G. Thurston, J.S. Rudge, E. Ioffe Angiopoietin-1 protects the adult vasculature against plasma leakage Nat Med 6 2000 460 463
55. R.O. Hynes Integrins Versatility, modulation, and signaling in cell adhesion Cell 69 1992 11 25
56. P.C. Brooks, R.A. Clark, D.A. Cheresh Requirement of vascular integrin alpha v beta 3 for angiogenesis Science 264 1994 569 571
57. P.C. Brooks, A.M. Montgomery, M. Rosenfeld Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels Cell 79 1994 1157 1164
58. P.C. Brooks, S. Stromblad, R. Klemke Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin J Clin Invest 96 1995 1815 1822
59. S.M. Frisch, H. Francis Disruption of epithelial cell-matrix interactions induces apoptosis J Cell Biol 124 1994 619 626
60. S. Stromblad, J.C. Becker, M. Yebra Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis J Clin Invest 98 1996 426 433
61. B.P. Eliceiri, D.A. Cheresh The role of alphav integrins during angiogenesis Insights into potential mechanisms of action and clinical development J Clin Invest 103 1999 1227 1230
62. O. Stoeltzing, W. Liu, N. Reinmuth Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice Int J Cancer 104 2003 496 503
63. N. Reinmuth, W. Liu, S.A. Ahmad Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice Cancer Res 63 2003 2079 2087
64. Y. Akagi, W. Liu, B. Zebrowski Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I Cancer Res 58 1998 4008 4014
65. C. Messa, F. Russo, M.G. Caruso EGF, TGF-alpha, and EGF-R in human colorectal adenocarcinoma Acta Oncol 37 1998 285 289
66. M. Kazuno, T. Tokunaga, Y. Oshika Thrombospondin-2 (TSP2) expression is inversely correlated with vascularity in glioma Eur J Cancer 35 1999 502 506
67. K. Maeda, Y. Nishiguchi, S.M. Kang Expression of thrombospondin-1 inversely correlated with tumor vascularity and hematogenous metastasis in colon cancer Oncol Rep 8 2001 763 766
68. G. Allegrini, F.A. Goulette, J.W. Darnowski Thrombospondin-1 plus irinotecan A novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice Cancer Chemother Pharmacol 53 2004 261 266
69. H. Hurwitz, L. Fehrenbacher, W. Novotny Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer N Engl J Med 350 2004 2335 2342
70. H. Kindler, R. Ansari, E. Lester Bevacizumab (B) plus gemcitabine (G) in patients (pts) with advanced pancreatic cancer (PC) Proc Am Soc Clin Oncol 22 2003 259 (abstr 1037)
71. K. Miller, H. Rugo, M. Cobleigh Phase III trial of capecitabine (Xeloda) plus bevacizumab (Avastin) versus capecitabine alone in women with metastatic breast cancer previously treated with an anthracycline and a taxane Breast Cancer Res Treat 76 2002 S37 (abstr)
72. L. Miller, G. Elfring, A. Hannah Efficacy results of a phase I/II study of SU5416 (S)/5-fluorouracil (F)/leucovorin (L) relative to results in random subsets of similar patients (pts) from a phase III study of irinotecan (C)/F/L or F/L alone in the therapy of previously untreated metastatic colorectal cancer Proc Am Soc Clin Oncol 20 2001 144a (abstr 571)
73. R.K. Jain Normalizing tumor vasculature with anti-angiogenic therapy A new paradigm for combination therapy Nat Med 7 2001 987 989
74. R.T. Tong, Y. Boucher, S.V. Kozin Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors Cancer Res 64 2004 3731 3736
75. Y. Boucher, R.K. Jain Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors Implications for vascular collapse Cancer Res 52 1992 5110 5114
76. Y. Boucher, M. Leunig, R.K. Jain Tumor angiogenesis and interstitial hypertension Cancer Res 56 1996 4264 4266
77. C.G. Lee, M. Heijn, E. di Tomaso Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions Cancer Res 60 2000 5565 5570
78. C.G. Willett, Y. Boucher, E. di Tomaso Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer Nat Med 10 2004 145 147
79. H. Wildiers, G. Guetens, G. De Boeck Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11 Br J Cancer 88 2003 1979 1986
80. J. Ma, S. Li, K. Reed Pharmacodynamic-mediated effects of the angiogenesis inhibitor SU5416 on the tumor disposition of temozolomide in subcutaneous and intracerebral glioma xenograft models J Pharmacol Exp Ther 305 2003 833 839
81. S. Rafii, D. Lyden, R. Benezra Vascular and haematopoietic stem cells Novel targets for anti-angiogenesis therapy? Nat Rev Cancer 2 2002 826 835
82. F. Fan, O. Stoeltzing, W. Liu Interleukin-1beta regulates angiopoietin-1 expression in human endothelial cells Cancer Res 64 2004 3186 3190